The US Food and Drug Administration (FDA) approved Leo Pharma’s great growth hope, tralokinumab, shortly before the New Year. Leo Pharma is now beginning to roll out the drug in the US.
This hasn’t stopped the pharmaceutical company from developing the treatment further, including the way patients are treated with the drug. Leo Pharma has just registered a new phase III trial with tralokinumab administered as subcutaneous injection using something only described as ”device A.”
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Zealand Pharma sells shares for over USD 100m
With a 5% discount, the biotech company managed to sell 4,975,000 of its own shares in a direct issuance.
Zealand Pharma CEO: Share sale arms us for partnership negotiations
After a study success with short bowel syndrome treatment candidate, the Danish biotech company raised funding by issuing shares, preparing the company’s CEO, Adam Steensberg, to enter dialogs with a number of potential partners.
Complete company divestment is not part of Zealand Pharma's strategy
After a Nordnet analyst brought up the possibility of the Danish company being an acquisition target for foreign firms, CEO Adam Steensberg has ruled out the notion of a full sale.
Three scientists share chemistry Nobel for cancer improvement technology breakthrough
Danish national Morten Meldal and two colleagues have been awarded the prestigious award for their research into click chemistry, which is used the development of cancer drugs.
Audientes builds on Q2 momentum, maintains guidance
The hearing aid company has sold self-fitting hearing aids for over DKK 2m (USD 266,700) during the third quarter that ended in September.
Quality Assurance & Regulatory Affairs Manager 
Senior Drug Product Specialist 
Calibration Technician 
CMC Writer 
Clinical Project Lead 
Sales Manager Denmark 
Product specialist 
Senior CMC Regulatory Manager 
Pharmacovigilance & Regulatory Officer 
Scientist Radiochemistry 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Experienced IT Business Solutions Manager for the Danish Medicines Agency